- Sprache
-
Englisch
- Identifier
-
1177252333
- Thema
-
Therapeutics; Melanoma; Cancer; Hochschulschrift
- Beteiligte Personen und Organisationen
- DOI
-
10.11588/heidok.00024785
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
The role of SOX2 in resistance towards targeted therapy
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Partial reprogramming - a model for melanoma targeted therapy resistance
Optimization of individualized therapy for colorectal cancers (CRCs) with secondary resistance towards targeted anti-EGFR treatment
Targeted cancer therapy
Cancer Evolution and the Emergence of Resistance to Targeted Cancer Therapy
Targeted Therapy beim Nierenzellkarzinom
Signal transduction and targeted therapy
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
The role of SOX2 in resistance towards targeted therapy
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Partial reprogramming - a model for melanoma targeted therapy resistance
Optimization of individualized therapy for colorectal cancers (CRCs) with secondary resistance towards targeted anti-EGFR treatment
Targeted cancer therapy
Cancer Evolution and the Emergence of Resistance to Targeted Cancer Therapy
Targeted Therapy beim Nierenzellkarzinom
Signal transduction and targeted therapy
Advances in targeted cancer therapy
Targeted Therapy in der Rheumatologie
The role of SOX2 in resistance towards targeted therapy
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Partial reprogramming - a model for melanoma targeted therapy resistance
Optimization of individualized therapy for colorectal cancers (CRCs) with secondary resistance towards targeted anti-EGFR treatment
Targeted cancer therapy
Cancer Evolution and the Emergence of Resistance to Targeted Cancer Therapy
Targeted Therapy beim Nierenzellkarzinom
Signal transduction and targeted therapy
Advances in targeted cancer therapy